SUMMIT, the landmark study conducted within the UK focused on diagnosing lung cancer before it becomes untreatable, has demonstrated the practicality and cost effectiveness of mass CT screening.
The University College London Hospital (UCLH), University College London and the National Institute for Health Research UCLH Biomedical Research Centre have been collaborating with US diagnostics company Grail to sponsor the SUMMIT lung-cancer screening trial.
The study will enroll a total of 25,000 people from London and the surrounding areas aged between 55 and 77. Enrolment started in April 2019, and is expected to end...
Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.
Roche aims to grow its diagnostics sales by mid to high single digits, said CEO of Roche Diagnostics Matt Sause. The company unveiled the Axelios synthesis and sequencing solution and discussed its “long-term commitment” to China, as well as its business strategy for the next five years.
Medtech Insight spoke with Hubert Martens, CEO of Netherlands-based neuromodulation company Salvia Bioelectronics, about the company’s innovative implant for treating chronic migraines, ongoing clinical trials and plans for US clinical trials and commercialization.
